User profiles for Jan C. Oosterwijk
 | Jan C. OosterwijkClinical Geneticist, MD, PhD Verified email at umcg.nl Cited by 14702 |
[HTML][HTML] Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
…, SH Muller, S Meijer, JC Oosterwijk… - … England Journal of …, 2004 - Mass Medical Soc
Background The value of regular surveillance for breast cancer in women with a genetic or
familial predisposition to breast cancer is currently unproven. We compared the efficacy of …
familial predisposition to breast cancer is currently unproven. We compared the efficacy of …
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
…, H Nevanlinna, JM Collée, MA Rookus, JC Oosterwijk… - Nature …, 2015 - nature.com
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC)
susceptibility alleles. The pattern of association at these loci is consistent in BRCA1 and …
susceptibility alleles. The pattern of association at these loci is consistent in BRCA1 and …
[HTML][HTML] Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
…, G Verhaegh, WA van Zelst-Stams, JC Oosterwijk… - European urology, 2014 - Elsevier
Background Men with germline breast cancer 1, early onset (BRCA1) or breast cancer 2,
early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) …
early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) …
[PDF][PDF] BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
…, MJ Hooning, M Kriege, PIM Schmitz, JC Oosterwijk… - 2010 - repository.ubn.ru.nl
… A B S T R A C T … Griebsch I, Brown J, Boggis C, et al: Costeffectiveness of screening
with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at …
with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at …
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
…, J de Vries, AH van der Hout, JC Oosterwijk - Breast cancer research …, 2010 - Springer
Accurate estimations of lifetime risks of breast and ovarian cancer are crucial for counselling
women from BRCA1/2 families. We therefore determined breast and ovarian cancer …
women from BRCA1/2 families. We therefore determined breast and ovarian cancer …
[HTML][HTML] Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers
…, L Taylor, M Salinas, L Feliubadaló, JC Oosterwijk… - European urology, 2019 - Elsevier
Background Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate
cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-…
cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-…
Rapid detection of BRCA1 mutations by the protein truncation test
…, RS Cornelis, M Bout, M Vliet, JC Oosterwijk… - Nature …, 1995 - nature.com
More than 75% of the reported mutations in the hereditary breast and ovarian cancer gene,
BRCA1, result in truncated proteins. We have used the protein truncation test (PIT) to screen …
BRCA1, result in truncated proteins. We have used the protein truncation test (PIT) to screen …
Inheritance of most X‐linked traits is not dominant or recessive, just X‐linked
The existence of X‐linked disorders in humans has been recognized for many centuries,
based on lessons in religious texts and observations of specific human families (eg, color …
based on lessons in religious texts and observations of specific human families (eg, color …
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial
Background Approximately 15% of all breast cancers occur in women with a family history
of breast cancer, but for whom no causative hereditary gene mutation has been found. …
of breast cancer, but for whom no causative hereditary gene mutation has been found. …
Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
…, BK Leegte, G Dijkhuis, JC Oosterwijk… - … Journal of Cancer, 2009 - Wiley Online Library
Women at high risk of ovarian cancer due to a genetic predisposition may opt for either
surveillance or prophylactic bilateral salpingo‐oophorectomy (pBSO). Main objective of our study …
surveillance or prophylactic bilateral salpingo‐oophorectomy (pBSO). Main objective of our study …
